Key result
Pretreatment with the selective ETA receptor antagonist BQ-123 inhibited endothelin-1-induced plasma volume loss by 87% and markedly attenuated protein extravasation in conscious rats.
Endothelin-1 enhances microvascular permeability and induces plasma volume loss in conscious rats, an effect that is largely mediated by ETA receptors.
ETA blockade attenuates ET-1 permeability in rats; leaves open clinical translation to edema or volume states.
The objective of the present experiments was to assess the involvement of endothelin-A (ETA) receptors in mediating the effects of endothelin-1 on microvascular permeability in conscious rats. 2. Bolus injection of endothelin-1 (0.1 and 1 nmol kg-1, i.v.) resulted in a dose-dependent prolonged pressor effect preceded by a transient depressor response. These changes were accompanied by a dose-dependent loss of plasma volume. Endothelin-1 (1 nmol kg-1) enhanced the vascular permeability of the upper and lower bronchi, kidney, stomach, duodenum and spleen (up to 270%) as measured by the extravasation of Evans blue dye. 3. Pretreatment of the animals with the selective ETA receptor antagonist, BQ-123 (1 mg kg-1, i.v.) significantly blunted the pressor response to endothelin-1 without affecting the depressor response. BQ-123 inhibited by 87% the endothelin-1 (1 nmol kg-1)-induced plasma volume loss. BQ-123 markedly attenuated protein extravasation elicited by endothelin-1 in the upper and lower bronchi and kidney, whereas it completely inhibited the permeability effect of endothelin-1 in the stomach and duodenum. BQ-123 by itself had no significant effect on the parameters studied. 4. The endothelin-1 analogue, [Trp(For)21]-endothelin-1, in which Trp21 is formylated, was as potent a pressor agent as endothelin-1, but had no depressor action. Bolus injection of [Trp(For)21]-endothelin-1 (0.1 and 1 nmol kg-1, i.v.) evoked similar plasma volume losses to those observed following administration of equimolar doses of endothelin-1. Furthermore, 1 nmol kg-1 [Trp(For)21]-endothelin-l evoked increases in protein extravasation similar to endothelin-l, 1 nmol kg-1.5. The present findings suggest that endothelin- 1 enhances microvascular permeability, in part, via the activation of ETA receptors.
No takes yet. Share an insight, caveat, or question.
Filep et al. (1993) studied Microvascular permeability. Endothelin-1 and BQ-123 was evaluated on Microvascular permeability (extravasation of Evans blue dye) and plasma volume loss. Pretreatment with the selective ETA receptor antagonist BQ-123 inhibited endothelin-1-induced plasma volume loss by 87% and markedly attenuated protein extravasation in conscious rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: